Cells (Jan 2022)

Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging

  • Mengping Liu,
  • Lin Wang,
  • Young Lo,
  • Simon Chi-Chin Shiu,
  • Andrew B. Kinghorn,
  • Julian A. Tanner

DOI
https://doi.org/10.3390/cells11010159
Journal volume & issue
Vol. 11, no. 1
p. 159

Abstract

Read online

A wide variety of nanomaterials have emerged in recent years with advantageous properties for a plethora of therapeutic and diagnostic applications. Such applications include drug delivery, imaging, anti-cancer therapy and radiotherapy. There is a critical need for further components which can facilitate therapeutic targeting, augment their physicochemical properties, or broaden their theranostic applications. Aptamers are single-stranded nucleic acids which have been selected or evolved to bind specifically to molecules, surfaces, or cells. Aptamers can also act as direct biologic therapeutics, or in imaging and diagnostics. There is a rich field of discovery at the interdisciplinary interface between nanomaterials and aptamer science that has significant potential across biomedicine. Herein, we review recent progress in aptamer-enabled materials and discuss pending challenges for their future biomedical application.

Keywords